A carregar...
Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression
AIM: Previous studies conducted primarily in the USA and Europe have demonstrated the efficacy and safety of lurasidone 20–120 mg/day for the treatment of bipolar I depression. The aim of the current study was to evaluate the efficacy and safety of lurasidone monotherapy for the treatment of bipolar...
Na minha lista:
| Publicado no: | Psychiatry Clin Neurosci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756283/ https://ncbi.nlm.nih.gov/pubmed/32827348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcn.13137 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|